Source: Breathe 2015; 11:39-48
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Flume Patrick A., Aitken Moira L., Bilton Diana, Agent Penny, Charlton Brett, Forster Emma, Fox Howard G., Hebestreit Helge, Kolbe John, Zuckerman Jonathan B, Button Brenda M.. Optimising inhaled mannitol for cystic fibrosis in an adult population. Breathe 2015; 11:39-48

Member's Comments

No comment yet.

Related content which might interest you: Inhaled mannitol as treatment for children with cystic fibrosis Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease Year: 2008 Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016 Year: 2017 Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis Source: Eur Respir J 2011; 37: 1091-1095 Year: 2011 Inhalation therapy in cystic fibrosis Source: School Course 2013 - Cystic Fibrosis Year: 2013 Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Efficacy of alendronate/colecalciferol/calcium in adults with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Benefit of aerosol therapy with pulmozyme for children with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 622s Year: 2005 Home intravenous antibiotic treatments in cystic fibrosis adult patients Source: Eur Respir J 2002; 20: Suppl. 38, 158s Year: 2002 Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020 A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation Source: Eur Respir J 2015; 45: 541-544 Year: 2015 Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Long-term tiotropium bromide therapy was retrospectively analyzed in adults with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Inhaled steroids in children with non-cystic fibrosis bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 392s Year: 2004 Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Source: Eur Respir J 2002; 20: 122-126 Year: 2002 RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006 Inhaled colistin following lung transplantation in colonised cystic fibrosis patients Source: Eur Respir J 2013; 42: 542-544 Year: 2013